These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7694305)
1. Effects of sennosides and nonanthranoid laxatives on cytochemistry of epithelial cells in rat colon. Yang K; Fan K; Mengs U; Lipkin M Pharmacology; 1993 Oct; 47 Suppl 1():196-204. PubMed ID: 7694305 [TBL] [Abstract][Full Text] [Related]
2. Effects of sennosides A + B and bisacodyl on rat large intestine. Leng-Peschlow E Pharmacology; 1989; 38(5):310-8. PubMed ID: 2762373 [TBL] [Abstract][Full Text] [Related]
3. Effects of sodium picosulfate, bisacodyl and sennoside in cultured human, rat and rabbit liver cells. Nishikawa J; Kast A Arzneimittelforschung; 1981; 31(6):1010-3. PubMed ID: 7196230 [TBL] [Abstract][Full Text] [Related]
4. Light and electron-microscopic changes in the colon of the guinea pig after treatment with anthranoid and non-anthranoid laxatives. Mengs U; Rudolph RL Pharmacology; 1993 Oct; 47 Suppl 1():172-7. PubMed ID: 8234426 [TBL] [Abstract][Full Text] [Related]
5. In vivo motility of rat colon chronically pretreated with sennosides. Fioramonti J; Dupuy C; Buéno L Pharmacology; 1993 Oct; 47 Suppl 1():155-61. PubMed ID: 8234424 [TBL] [Abstract][Full Text] [Related]
6. Effects of 'contact laxatives' on intestinal and colonic epithelial cell proliferation. Geboes K; Nijs G; Mengs U; Geboes KP; Van Damme A; de Witte P Pharmacology; 1993 Oct; 47 Suppl 1():187-95. PubMed ID: 8234428 [TBL] [Abstract][Full Text] [Related]
7. bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM)-the active metabolite of the laxatives bisacodyl and sodium picosulfate-enhances contractility and secretion in human intestine in vitro. Krueger D; Demir IE; Ceyhan GO; Zeller F; Schemann M Neurogastroenterol Motil; 2018 Jul; 30(7):e13311. PubMed ID: 29441646 [TBL] [Abstract][Full Text] [Related]
8. Effects of long-term treatment with anthranoids and sodium picosulphate on the contents of vasoactive intestinal polypeptide, somatostatin and substance P in the rat colon. Tzavella K; Schenkirsch G; Riepl RL; Odenthal KP; Leng-Peschlow E; Müller-Lissner SA Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):13-20. PubMed ID: 7532534 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Sodium Picosulfate/Magnesium Citrate for Bowel Preparation in a Physically Disabled Outpatient Population: A Randomized, Endoscopist-Blinded Comparison With Ascorbic Acid-Enriched Polyethylene Glycol Solution Plus Bisacodyl (The PICO-MOVI Study). Mathus-Vliegen EMH; van der Vliet K; Wignand-van der Storm IJ; Stadwijk JS Dis Colon Rectum; 2018 Feb; 61(2):239-249. PubMed ID: 29337780 [TBL] [Abstract][Full Text] [Related]
10. Cytokeratin, lectin, and acidic mucin modulation in differentiating colonic epithelial cells of mice after feeding Western-style diets. Yang K; Fan K; Newmark H; Leung D; Lipkin M; Steele VE; Kelloff GJ Cancer Res; 1996 Oct; 56(20):4644-8. PubMed ID: 8840978 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of bowel-cleansing agents: implications of antibacteroides activity of senna. Chapman MA; Abercrombie J; Livermore DM; Williams NS Br J Surg; 1995 Aug; 82(8):1053. PubMed ID: 7648151 [No Abstract] [Full Text] [Related]
13. Screening procedure for detection of stimulant laxatives and/or their metabolites in human urine using gas chromatography-mass spectrometry after enzymatic cleavage of conjugates and extractive methylation. Beyer J; Peters FT; Maurer HH Ther Drug Monit; 2005 Apr; 27(2):151-7. PubMed ID: 15795644 [TBL] [Abstract][Full Text] [Related]
14. Acceleration of large intestine transit time in rats by sennosides and related compounds. Leng-Peschlow E J Pharm Pharmacol; 1986 May; 38(5):369-73. PubMed ID: 2872313 [TBL] [Abstract][Full Text] [Related]
15. [The mechanism of action of sennosides]. Lemli J Ann Gastroenterol Hepatol (Paris); 1996; 32(2):109-12. PubMed ID: 8737510 [TBL] [Abstract][Full Text] [Related]
16. Sennoside-induced secretion is not caused by changes in mucosal permeability or Na+,K(+)-ATPase activity. Leng-Peschlow E J Pharm Pharmacol; 1993 Nov; 45(11):951-4. PubMed ID: 7908035 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of cell proliferation and prostaglandin biosynthesis by 1,8-dihydroxyanthraquinone in the rat large intestine. Nishikawa A; Kase Y; Hayakawa T; Yanagisawa T; Kanno J; Hayashi Y Carcinogenesis; 1997 Jun; 18(6):1259-63. PubMed ID: 9214611 [TBL] [Abstract][Full Text] [Related]
18. Split-dose administration of a dual-action, low-volume bowel cleanser for colonoscopy: the SEE CLEAR I study. Rex DK; Katz PO; Bertiger G; Vanner S; Hookey LC; Alderfer V; Joseph RE Gastrointest Endosc; 2013 Jul; 78(1):132-41. PubMed ID: 23566639 [TBL] [Abstract][Full Text] [Related]
19. Some aspects of the pharmacology of anthraquinone drugs. van Os FH Pharmacology; 1976; 14 Suppl 1():18-29. PubMed ID: 790404 [No Abstract] [Full Text] [Related]
20. Current concepts of laxative action: mechanisms by which laxatives increase stool water. Donowitz M J Clin Gastroenterol; 1979 Mar; 1(1):77-84. PubMed ID: 95606 [No Abstract] [Full Text] [Related] [Next] [New Search]